A Genetic Model of RPE Dysfunction in ARMD
About the Research Project
Program
Award Type
Standard
Award Amount
$150,000
Active Dates
April 01, 2006 - June 30, 2008
Grant ID
M2006024
Goals
This project will analyze the effects of vacuolar ATPase mutations in zebrafish, an animal model system in which human diseases can be studied. Zebrafish vacuolar ATPase mutants show severe AMD-like pathologies in their eyes and are, therefore, an excellent animal model system in which AMD progression can be further understood.
Grantee institution at the time of this grant: The University of Texas at Austin
Summary
In patients with the dry form of age-related macular degeneration (ARMD), a substance called drusen builds up in cells of the retinal pigment epithelium (RPE) – the pigmented layer at the back of the eye. Drusen poisons RPE cells by inhibiting their ability to degrade protein and lipid components of photoreceptors – the light-sensitive cells of the retina. Normally, RPE cells help to maintain the survival of photoreceptors by continually removing their tips, which have accumulated cellular damage over time. Dr. Gross will study the mechanisms that RPE cells utilize to facilitate photoreceptor degradation, focusing on a protein complex called the vacuolar ATPase that is necessary for degradative processes in other cell types. Dr. Gross predicts that mutations in the vacuolar ATPase complex lead to ARMD in humans.
Grants
Related Grants
Macular Degeneration Research
Investigating AMD-Like Disease in Animal Models
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Brittany Carr, PhD
Investigating AMD-Like Disease in Animal Models
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Brittany Carr, PhD
Macular Degeneration Research
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Heike Kroeger, PhD
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Heike Kroeger, PhD
Macular Degeneration Research
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD